Elicio Therapeutics, Inc. reports

Company Who this page is about. 1 identity field
Location
Boston, MA
SEC filing record 1 source field
Fiscal year end
31 December
Elicio Therapeutics, Inc. has filed 360 SEC EDGAR filings since 04 Mar 2014

SEC filing history

Showing 76-100 of 360 matching filings.

Per page
25
Current page
4
4

FORM 4

Filing date
25 Nov 2024
Reporting date
21 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-283199

424B3

Filing date
22 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-283199

EFFECT filing

Filing date
20 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
18 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-283199

UPLOAD filing

Filing date
15 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-283199

S-3

Filing date
13 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Oct 2024
Reporting date
30 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Oct 2024
Reporting date
30 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Oct 2024
Reporting date
30 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-39990

ARS

Filing date
27 Sep 2024
Reporting date
31 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-39990

DEF 14A

Filing date
27 Sep 2024
Reporting date
07 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-39990

PRE 14A

Filing date
17 Sep 2024
Reporting date
07 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-93548

GKCC, LLC ELICIO THERAPEUTICS, INC. SCHEDULE 13D/A

Filing date
14 Aug 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
14 Aug 2024
Reporting date
12 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Jul 2024
Reporting date
28 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .